Malaysian Association of Pharmaceutical Suppliers (MAPS)
President's Message - February 2021
The last month has not been easy for our nation as we grapple with the highest daily records for Covid-19 cases, and the implementation of MCO 2.0 as well as an Emergency declaration. However the first few days of this month has seen a gradual decline in cases, albeit still registering high numbers. It has been stated by the Ministiry of Science Technology and Innovation that the vaccine will be delivered one week earlier than expected for the end of this month to enable phase one of the Vaccination roll-out.
For the past month we have been engaged in various discussions on the proposed Medicine Price Control. We thank all our members for providing feedback on the Cost Benefit Analysis via the United Public Consultation web portal. We continue to be engaged in discussing this matter, as of writing of this message.
MAPS was invited in January to provide feedback to the Ministry of International Trade and Industry on the proposal by India and South Africa to the World Trade Organization on "Waiver From Certain Provisions Of The Trips Agreement For The Prevention, Containment And Treatment Of Covid-19". We have provided our feedback in the direct meeting with MITI.
Our Annual General Meeting is scheduled for next month 18th March, and barring any further extensions, we hope to see everyone for this AGM where we will be electing the new board to lead us through the challenges,with your strong support.
As the new year of the Ox approaches, although celebrations this year will be rather muted, I trust that we will all do our best to stay safe, and healthy. I wish all a Happy Chinese New Year, and may the challenges turn into opportunities.
LIM TENG CHYUAN
Also on this page: links for Membership Application Form, Code of Conduct, Membership list, Member login
If you would like to read previous messages by the President, please visit our archive (click this)
Foreword by the PresidentI am delighted to welcome you to the MAPS website and I hope you will find the information provided here to be useful for the pharmaceutical industry in Malaysia.
I welcome participation from members to be active in subcommittees that have been formed in order to make MAPS an association where everyone can openly suggest, exchange ideas, share issues and values of common interests. Membership of MAPS is open to any company involved in pharmaceutical trade (importer and / or distributor) in Malaysia.
I look forward to warmly welcome you into MAPS.
Why we exist
The first gathering of “like-minded” interest Group for the formation of the “Malaysian Association of Pharmaceutical Suppliers (MAPS)” was on 17th March 2011 held in the premise of Medispec, Taman Mayang, Petaling Jaya.
MAPS was formally registered with the Registrar of Society on the 17th November 2011.
It was formed to fill in the "missing piece" in the trade representation in the Pharmaceutical Industry.
MAPS is having representations and engaging with the relevant Government bodies like the Bahagian Farmasi, BPFK, PEMANDU, MyCC, etc, on issues relating to the pharmaceutical trade.
MAPS is in the forefront of issues facing the Industry which means that the voices and interests of MAPS will be heard and considered. Thus, MAPS will have the opportunity to continuously collaborate and consult on the policies and regulations affecting the industry.
Board of Directors
Lim Teng Chyuan
Heng Thin Fook
Choe Tong Seng
Yeo Ann Chin
Dharshen Kumar A/L Thirunahaikarasu
Choe Tong Seng
Board of Directors of former terms
If your company qualifies to be a member, and in concurrence with our goals, please apply for membership. Click here for the membership form.
Technical Working Groups/ External committees
MAPS practises a high ethical code. Members are required to abide by this conduct to ensure that the industry maintains a high level of integrity. Click here for MAPS' code of conduct.
Members of MAPS are Malaysian Companies which import pharmaceuticals into the country. They represent principals from Europe, North America, Asia, Oceania etc. The principals may be R&D or generic manufacturers from these regions.
|Ethics||Lim Teng Chyuan||Somedico|
|Regulatory||Yeo Ann Chin||Pharmaforte|
|Social & Sports||Mathew John||Jetpharma|
|Trade Practices||Heng Thin Fook||Medispec|
As an association, MAPS is committed to build the industry together with the respective government authorities and the industry stakeholders. The country has to have an industry that is conducive to attract investments with an ecosystem of "fairness, healthy, vibrancy, dynamic, skill and knowledgeable" and "an equitable, accessible and affordable healthcare for the rakyat in the country".
Click on this to view the membership list.
Click here to enter the members-only pages.